Seretide Metered Dose Inhaler 250/25 mcg - Fluticasone Propionate

Seretide Metered Dose Inhaler 250/25 mcg

Introducing the Seretide Metered Dose Inhaler, a powerful combination of Fluticasone Propionate and Salmeterol Xinafoate designed to manage asthma and chronic obstructive pulmonary disease (COPD). This inhaler is engineered to deliver precise doses of medication, ensuring effective control of respiratory symptoms.

• Contains 250 mcg of Fluticasone Propionate and 25 mcg of Salmeterol Xinafoate per dose.
• Designed for regular use to maintain optimal respiratory function.
• Not intended for acute asthma attacks.

• Seretide MDI 250/25 mcg

• Active Ingredients Fluticasone Propionate, Salmeterol Xinafoate
• Dosage Form Metered Dose Inhaler

• Ideal for individuals with asthma or COPD requiring regular treatment.

• Patients with moderate to severe respiratory conditions.

GlaxoSmithKline (GSK) is a leading global healthcare company known for its innovative respiratory treatments. With a commitment to improving quality of life, GSK continues to pioneer advancements in respiratory care.